Concepedia

Sigal Kaplan

SK

14

Publications

426

Citations

12

H-Index

2002

Active since

Affiliations

Teva Pharmaceuticals (Israel)(Current)

Center for Drug Evaluation and Research

University Medical Center Utrecht

Harvard Pilgrim Health Care

United States Food and Drug Administration

Sigal Kaplan is an author at Teva Pharmaceuticals (Israel) specializing in public health, medicine, and maternal health.

ORCID

Top concepts

Publications per year

2002–2024

14

Publications

14

Reported Adverse Drug Events in Infants and Children Under 2 Years of Age

Thomas J. Moore, Sheila R. Weiss, Sigal Kaplan et al. · PEDIATRICS · 2002 · 137 citations

Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions

Carol Pamer, Tarek A. Hammad, Yute Wu et al. · Pharmacoepidemiology and Drug Safety · 2010 · 48 citations

Medication Exposure in Pregnancy Risk Evaluation Program: The Prevalence of Asthma Medication Use During Pregnancy

Craig Hansen, Peter Joski, Heather Freiman et al. · Maternal and Child Health Journal · 2012 · 45 citations

, , +12

Prevalence, Trends, and Patterns of Use of Antidiabetic Medications Among Pregnant Women, 2001-2007

Jean M. Lawrence, Susan E. Andrade, Lyndsay A. Avalos et al. · Obstetrics and Gynecology · 2013 · 28 citations · Full text

Assessing Heterogeneity of Treatment Effect in Real-World Data

Jodi B Segal, Ravi Varadhan, Rolf H. H. Groenwold et al. · Annals of Internal Medicine · 2023 · 27 citations · Full text

Rows per page

1–5 of 14